Advanced company searchLink opens in new window

SUGARCANE BIOPRODUCTS (HOLDINGS) LIMITED

Company number 10778679

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
06 Jun 2018 CS01 Confirmation statement made on 17 May 2018 with updates
06 Jun 2018 PSC07 Cessation of Adam Swarbrick as a person with significant control on 6 March 2018
13 Mar 2018 SH08 Change of share class name or designation
13 Mar 2018 SH02 Sub-division of shares on 6 March 2018
13 Mar 2018 SH10 Particulars of variation of rights attached to shares
09 Mar 2018 RESOLUTIONS Resolutions
  • RES13 ‐ Sub div new class of share 06/03/2018
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
  • RES12 ‐ Resolution of varying share rights or name
08 Mar 2018 SH01 Statement of capital following an allotment of shares on 7 March 2018
  • GBP 16,276.7
08 Mar 2018 SH01 Statement of capital following an allotment of shares on 7 March 2018
  • GBP 1,591.36
08 Mar 2018 SH01 Statement of capital following an allotment of shares on 6 March 2018
  • GBP 1,577.7
27 Feb 2018 TM01 Termination of appointment of Adam Swarbrick as a director on 16 February 2018
27 Feb 2018 AP01 Appointment of Mr Alan Adi Yazdabadi as a director on 16 February 2018
18 May 2017 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted

Statement of capital on 2017-05-18
  • GBP 1